www.appletreepartners.com Open in urlscan Pro
134.122.25.176  Public Scan

Form analysis
0 forms found in the DOM

Text Content

A T P
 * About
 * Team
 * Portfolio
 * ATP R&D
 * News
 * Locations
 * Contact

APPLE TREE PARTNERS (ATP). A PIONEER IN LIFE SCIENCES VENTURE CAPITAL, IS
DEVELOPING THE NEXT GENERATION OF TRANSFORMATIVE BIOTECHNOLOGY COMPANIES.

WE CREATE SCIENCE-BASED COMPANIES STARTING WITH ASSETS AT VARIOUS STAGES: FROM
WORKING WITH SCIENTISTS ON PRE-IP IDEAS, TO SPINOUTS FROM EXISTING COMPANY
PIPELINES.

WE PROVIDE FLEXIBLE CAPITAL, STRATEGIC INSIGHT, AND OPERATIONAL RESOURCES TO
BUILD SUSTAINABLE, RESEARCH-DRIVEN ENTERPRISES.

WE INVEST IN OUR COMPANIES FROM SEED STAGE THROUGH IPO AND BEYOND, AND WE
SUPPORT OUR MANAGEMENT TEAMS IN STRATEGIC TRANSACTIONS AND SYNERGISTIC BUSINESS
COMBINATIONS.


RECENT NEWS


 * Mar 01, 2023
   Marengo Therapeutics Appoints Kevin Chin, MD, MS as Chief Medical Officer
 * Mar 01, 2023
   Galvanize Therapeutics Announces First Human Use of QuickShot: A Novel
   Contact-Sensing, Large Area, Focal Pulsed Electric Field Mapping and Ablation
   Catheter
 * Feb 17, 2023
   Gene editing: DNA versus RNA (Drug Discovery News)
 * Feb 01, 2023
   First U.S. Patient Dosed in Aulos Bioscience’s Phase 1/2 Clinical Trial of
   AU-007, a Novel IL-2 Therapeutic for the Treatment of Solid Tumors
 * Jan 27, 2023
   Marengo Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical
   Trial of its Novel TCR Vβ Directed Antibody-Fusion Molecule STAR0602, in
   Cancer Patients Refractory to Anti-PD1 Therapy
 * Jan 17, 2023
   Why I invited investors into my lab: Adendra Therapeutics co-founder Caetano
   Reis e Sousa in conversation with The Francis Crick Institute


 * © Apple Tree Partners
 * All rights reserved.
 * Website Terms of Use